Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
- PMID: 18280333
- PMCID: PMC2335370
- DOI: 10.1016/j.jaad.2007.11.020
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
Abstract
Background: Merkel cell carcinoma (MCC) is an aggressive skin cancer with a mortality of 33%. Advanced disease at diagnosis is a poor prognostic factor, suggesting that earlier detection may improve outcome. No systematic analysis has been published to define the clinical features that are characteristic of MCC.
Objective: We sought to define the clinical characteristics present at diagnosis to identify features that may aid clinicians in recognizing MCC.
Methods: We conducted a cohort study of 195 patients given the diagnosis of MCC between 1980 and 2007. Data were collected prospectively in the majority of cases, and medical records were reviewed.
Results: An important finding was that 88% of MCCs were asymptomatic (nontender) despite rapid growth in the prior 3 months (63% of lesions) and being red or pink (56%). A majority of MCC lesions (56%) were presumed at biopsy to be benign, with a cyst/acneiform lesion being the single most common diagnosis (32%) given. The median delay from lesion appearance to biopsy was 3 months (range 1-54 months), and median tumor diameter was 1.8 cm. Similar to earlier studies, 81% of primary MCCs occurred on ultraviolet-exposed sites, and our cohort was elderly (90% >50 years), predominantly white (98%), and often profoundly immune suppressed (7.8%). An additional novel finding was that chronic lymphocytic leukemia was more than 30-fold overrepresented among patients with MCC.
Limitations: The study was limited to patients seen at a tertiary care center. Complete clinical data could not be obtained on all patients. This study could not assess the specificity of the clinical characteristics of MCC.
Conclusions: To our knowledge, this study is the first to define clinical features that may serve as clues in the diagnosis of MCC. The most significant features can be summarized in an acronym: AEIOU (asymptomatic/lack of tenderness, expanding rapidly, immune suppression, older than 50 years, and ultraviolet-exposed site on a person with fair skin). In our series, 89% of primary MCCs had 3 or more of these findings. Although MCC is uncommon, when present in combination, these features may indicate a concerning process that would warrant biopsy. In particular, a lesion that is red and expanding rapidly yet asymptomatic should be of concern.
Figures


Similar articles
-
Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).J Am Acad Dermatol. 2015 Dec;73(6):968-75. doi: 10.1016/j.jaad.2015.08.041. Epub 2015 Oct 2. J Am Acad Dermatol. 2015. PMID: 26433246 Free PMC article.
-
Merkel cell carcinoma in Taiwan: a subset is chronic arsenicism-related, and the Merkel cell polyomavirus-negative cases are pathologically distinct from virus-related cases with a poorer outcome.Pathology. 2025 Apr;57(3):311-319. doi: 10.1016/j.pathol.2024.09.019. Epub 2024 Dec 29. Pathology. 2025. PMID: 39939227
-
Merkel cell carcinoma overlapping Bowen's disease: two cases report and literature review.J Cancer Res Clin Oncol. 2024 Apr 26;150(4):217. doi: 10.1007/s00432-024-05743-0. J Cancer Res Clin Oncol. 2024. PMID: 38668799 Free PMC article. Review.
-
Merkel cell carcinoma of the forehead area: a literature review and case report.Oral Maxillofac Surg. 2019 Sep;23(3):365-373. doi: 10.1007/s10006-019-00793-y. Epub 2019 Jul 24. Oral Maxillofac Surg. 2019. PMID: 31342210 Review.
-
Usefulness of ulceration and hyperkeratosis as clinical predictors of Merkel cell polyomavirus-negative and combined Merkel cell carcinoma: A retrospective study.J Dermatol. 2019 Feb;46(2):103-109. doi: 10.1111/1346-8138.14743. Epub 2018 Dec 19. J Dermatol. 2019. PMID: 30565285
Cited by
-
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice.J Virol Methods. 2013 Jan;187(1):6-14. doi: 10.1016/j.jviromet.2012.10.001. Epub 2012 Oct 18. J Virol Methods. 2013. PMID: 23085629 Free PMC article.
-
Role of sentinel lymph node biopsy in the management of merkel cell carcinoma.J Skin Cancer. 2012;2012:176173. doi: 10.1155/2012/176173. Epub 2012 Oct 3. J Skin Cancer. 2012. PMID: 23091725 Free PMC article.
-
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.Curr Treat Options Oncol. 2013 Jun;14(2):249-63. doi: 10.1007/s11864-013-0225-9. Curr Treat Options Oncol. 2013. PMID: 23436166 Free PMC article.
-
Merkel cell carcinoma of left groin: a case report and literature review.Case Rep Oncol Med. 2013;2013:431743. doi: 10.1155/2013/431743. Epub 2013 May 21. Case Rep Oncol Med. 2013. PMID: 23762689 Free PMC article.
-
Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma.Front Oncol. 2021 Mar 3;11:625360. doi: 10.3389/fonc.2021.625360. eCollection 2021. Front Oncol. 2021. PMID: 33747940 Free PMC article.
References
-
- Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300–9. - PubMed
-
- Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89(1):1–4. - PubMed
-
- Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–41. - PubMed
-
- Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127(9):2100–3. - PubMed
-
- Goepfert H, Remmler D, Silva E, Wheeler B. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol. 1984;110(11):707–12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical